Trial intelligence / Profile preview

Riluzole for Spasticity in Chronic Spinal Cord Injury

NCT02859792Phase 2Unknown

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
May 2019
Primary completion
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of riluzole in spasticity, sponsored by Assistance Publique-Hôpitaux de Marseille. Status: unknown.

02

Drugs

riluzole
03

Conditions

spasticity

Beyond the preview

Go deeper on NCT02859792.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02859792.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call